Примери за използване на Pharmacokinetic study на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Paediatric population pharmacokinetic study.
A second pharmacokinetic study was carried out in order to confirm the dose.
However it is important that this be confirmed in an appropriate pharmacokinetic study.
Confirmatory Pharmacokinetic Study(study code: 2009-2106).
The mean peak serum imiquimod concentration at the end of the pharmacokinetic study was 0.323 ng/mL.
A pharmacokinetic study in patients with renal impairment has not been conducted.
This study was primarily designed as a pharmacokinetic study(see section 5.2).
No pharmacokinetic study has been performed in patients with hepatic insufficiency.
Sonidegib has not been studied in a dedicated pharmacokinetic study in patients with renal impairment.
A pharmacokinetic study has shown that Instanyl single-dose and multi-dose nasal spray are bioequivalent.
Vomiting starts before the Cmax in plasma is reached;at 4-6 minutes in a pharmacokinetic study in dogs.
Shire will conduct a pharmacokinetic study in young and elderly patients with ET.
Renagel is not absorbed from the gastrointestinal tract according to a single dose pharmacokinetic study in healthy volunteers.
In a pharmacokinetic study in dogs the oromucosal mean bioavailability of dexmedetomidine was 28%.
The apparent half-life following topical dosing of 3.75% imiquimod cream in the pharmacokinetic study was calculated as approximately 29 hours.
A pharmacokinetic study with indinavir has shown a 28% decrease in AUC and a 36% decrease in Cmax for indinavir.
Patients in the second pivotal study had earlier participated in the Instanyl pharmacokinetic study or in the first pivotal study. .
In a pharmacokinetic study(n=24) BMI appeared to have little impact on systemic exposure to CE and BZA.
Effect of gastric acid reducing active substances on osimertinib In a clinical pharmacokinetic study, co-administration of omeprazole did not result in clinically relevant changes in osimertinib exposures.
A pharmacokinetic study was carried out in target animals at the recommended dose(14 mg/kg bodyweight of paromomycin).
Re-examination of these data and also taking into account the two expert reports submitted by the MAH,confirmed that the results of the pharmacokinetic study are not reliable for loratadine.
A single-dose pharmacokinetic study has been conducted with naltrexone/ bupropion in patients with hepatic impairment.
Safety data are based on patients with haematological malignancies enrolled in randomised, placebocontrolled clinical studies, including one pharmacokinetic study, and post marketing experience.
In a multiple-dose pharmacokinetic study in healthy volunteers, steady state was reached by day 5 of dosing.
The palifermin clinical program in the setting of myelotoxic therapy requiring haematopoietic stem cell(HSC) support included 650 patients with haematologic malignancies enrolled in 3 randomised,placebo-controlled clinical studies and a pharmacokinetic study.
In a pharmacokinetic study evaluating Omidria, systemic exposure to both phenylephrine and ketorolac was minimal and transient.
Active substances that may decrease osimertinib plasma concentrations In a clinical pharmacokinetic study in patients, the steady-state AUC of osimertinib was reduced by 78% when co-administered with rifampicin(600 mg daily for 21 days).
A pharmacokinetic study was conducted with human serum albumin-paclitaxel nanoparticles and carboplatin in non-small cell lung cancer patients.
The study was primarily designed as a pharmacokinetic study(see section 5.2), and efficacy endpoints were only exploratory.
A pharmacokinetic study in older healthy volunteers did not show a significant difference in pharmacokinetic parameters compared with younger adults.